| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |